124 related articles for article (PubMed ID: 26894856)
1. Ubiquitin ligase UBE3C promotes melanoma progression by increasing epithelial-mesenchymal transition in melanoma cells.
Tang L; Yi XM; Chen J; Chen FJ; Lou W; Gao YL; Zhou J; Su LN; Xu X; Lu JQ; Ma J; Yu N; Ding YF
Oncotarget; 2016 Mar; 7(13):15738-46. PubMed ID: 26894856
[TBL] [Abstract][Full Text] [Related]
2. The ubiquitin ligase UBE4A inhibits prostate cancer progression by targeting interleukin-like EMT inducer (ILEI).
Sun Y; Jia X; Gao Q; Liu X; Hou L
IUBMB Life; 2017 Jan; 69(1):16-21. PubMed ID: 27862841
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the ubiquitin ligase UBE3C in hepatocellular carcinoma revealed by exome sequencing.
Jiang JH; Liu YF; Ke AW; Gu FM; Yu Y; Dai Z; Gao Q; Shi GM; Liao BY; Xie YH; Fan J; Huang XW; Zhou J
Hepatology; 2014 Jun; 59(6):2216-27. PubMed ID: 24425307
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin-protein ligase E3C promotes glioma progression by mediating the ubiquitination and degrading of Annexin A7.
Pan SJ; Zhan SK; Ji WZ; Pan YX; Liu W; Li DY; Huang P; Zhang XX; Cao CY; Zhang J; Bian LG; Sun B; Sun QF
Sci Rep; 2015 Jun; 5():11066. PubMed ID: 26067607
[TBL] [Abstract][Full Text] [Related]
5. UBE3C promotes growth and metastasis of renal cell carcinoma via activating Wnt/β-catenin pathway.
Wen JL; Wen XF; Li RB; Jin YC; Wang XL; Zhou L; Chen HX
PLoS One; 2015; 10(2):e0115622. PubMed ID: 25658088
[TBL] [Abstract][Full Text] [Related]
6. Ubiquitin-protein ligase E3C maintains non-small-cell lung cancer stemness by targeting AHNAK-p53 complex.
Gu J; Mao W; Ren W; Xu F; Zhu Q; Lu C; Lin Z; Zhang Z; Chu Y; Liu R; Ge D
Cancer Lett; 2019 Feb; 443():125-134. PubMed ID: 30503554
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C inhibitor Gö6976 but not Gö6983 induces the reversion of E- to N-cadherin switch and metastatic phenotype in melanoma: identification of the role of protein kinase D1.
Merzoug-Larabi M; Spasojevic C; Eymard M; Hugonin C; Auclair C; Karam M
BMC Cancer; 2017 Jan; 17(1):12. PubMed ID: 28056869
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase TRIM56 inhibits ovarian cancer progression by targeting vimentin.
Zhao L; Zhang P; Su XJ; Zhang B
J Cell Physiol; 2018 Mar; 233(3):2420-2425. PubMed ID: 28771721
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition during invasion of cutaneous squamous cell carcinoma is paralleled by AKT activation.
Barrette K; Van Kelst S; Wouters J; Marasigan V; Fieuws S; Agostinis P; van den Oord J; Garmyn M
Br J Dermatol; 2014 Nov; 171(5):1014-21. PubMed ID: 24628329
[TBL] [Abstract][Full Text] [Related]
10. Role of epithelial-mesenchymal transition involved molecules in the progression of cutaneous melanoma.
Murtas D; Maxia C; Diana A; Pilloni L; Corda C; Minerba L; Tomei S; Piras F; Ferreli C; Perra MT
Histochem Cell Biol; 2017 Dec; 148(6):639-649. PubMed ID: 28828681
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA circPOLR2A promotes clear cell renal cell carcinoma progression by facilitating the UBE3C-induced ubiquitination of PEBP1 and, thereby, activating the ERK signaling pathway.
Xu Z; Chen S; Liu R; Chen H; Xu B; Xu W; Chen M
Mol Cancer; 2022 Jul; 21(1):146. PubMed ID: 35840930
[TBL] [Abstract][Full Text] [Related]
12. Novel WWP2 ubiquitin ligase isoforms as potential prognostic markers and molecular targets in cancer.
Soond SM; Smith PG; Wahl L; Swingler TE; Clark IM; Hemmings AM; Chantry A
Biochim Biophys Acta; 2013 Dec; 1832(12):2127-35. PubMed ID: 23938591
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Mesenchymal Expression Phenotype of Primary Melanoma and Matched Metastases and Relationship with Overall Survival.
Yan S; Holderness BM; Li Z; Seidel GD; Gui J; Fisher JL; Ernstoff MS
Anticancer Res; 2016 Dec; 36(12):6449-6456. PubMed ID: 27919967
[TBL] [Abstract][Full Text] [Related]
14. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
15. Oncogenic UBE3C promotes breast cancer progression by activating Wnt/β-catenin signaling.
Hang C; Zhao S; Wang T; Zhang Y
Cancer Cell Int; 2021 Jan; 21(1):25. PubMed ID: 33407510
[TBL] [Abstract][Full Text] [Related]
16. CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells.
Lupia A; Peppicelli S; Witort E; Bianchini F; Carloni V; Pimpinelli N; Urso C; Borgognoni L; Capaccioli S; Calorini L; Lulli M
J Invest Dermatol; 2014 Dec; 134(12):2947-2956. PubMed ID: 24940653
[TBL] [Abstract][Full Text] [Related]
17. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
18. Expression of epithelial-mesenchymal transition markers at the invasive front of oral squamous cell carcinoma.
Costa LC; Leite CF; Cardoso SV; Loyola AM; Faria PR; Souza PE; Horta MC
J Appl Oral Sci; 2015; 23(2):169-78. PubMed ID: 26018309
[TBL] [Abstract][Full Text] [Related]
19. Expression of monoacylglycerol lipase as a marker of tumour invasion and progression in malignant melanoma.
Baba Y; Funakoshi T; Mori M; Emoto K; Masugi Y; Ekmekcioglu S; Amagai M; Tanese K
J Eur Acad Dermatol Venereol; 2017 Dec; 31(12):2038-2045. PubMed ID: 28681540
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of Bmi-1 suppresses epithelial‑mesenchymal transition in melanoma.
Liu Y; Chu Z; Li Q; Peng B; Xu S; Lian CG; Geng S
Oncol Rep; 2017 Jan; 37(1):139-146. PubMed ID: 27878257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
